RGD-HSA-TAC nanoparticles targeted delivery of tacrolimus and attenuation of podocyte injury in diabetic kidney disease
Abstract Background Diabetic kidney disease (DKD) is a prevalent and severe complication of diabetes and plays a pivotal role in the pathogenesis and progression of DKD. However, the current clinical application of the treatment methods does not yield effective results. Tacrolimus has been utilized...
Saved in:
Main Authors: | Zhaochen Guo, Shaohui Gao, Feng Xu, Zige Chen, Qinger Wang, Zhaojie Liu, Ziyue Wang, Weisong Qin, Caihong Zeng, Zhihong Liu, Hao Bao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-025-03108-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination
by: Peterka Tanja Rozman, et al.
Published: (2019-09-01) -
Bridging Molecular Docking to Molecular Dynamics to Enlighten Recognition Processes of Tailored D-A/D-A-D Types' AIEgens with HSA/BSA
by: Harun Nalçakan, et al.
Published: (2023-09-01) -
Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant Patients
by: Alan D. Kaye, et al.
Published: (2024-12-01) -
Tacrolimus trough level and oxidative stress in Tunisian kidney transplanted patients
by: Mariam Ammar, et al.
Published: (2024-12-01) -
Evaluation of efficacy and safety of generic tacrolimus (Suprotac®) compared to reference tacrolimus (Prograf<sup>®</sup>) in kidney transplantation: a phase IV study
by: Behzad Einollahi, et al.
Published: (2025-01-01)